ArriVent BioPharma, Inc.

AVBP Healthcare Biotechnology

In the quarter to June 2026, EPS fell 16.7% and free cash flow fell 51.5%, each against the same quarter a year earlier.

16.66 0.13 −0.77%
Market cap
$827.9M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Older periods Sep '25 Dec '25 Mar '26 Jun '26
Cash and Short Term Investments

+8 more quarters

300.27 312.82 326.38 373.12
Total current assets
321.22 332.90 348.70 394.17
Long-Term Investments
5.11 — — —
Long-term assets (Other)
0.18 0.19 0.16 0.13
Total non-current assets
5.34 0.27 0.60 0.55
Total Assets
326.56 333.17 349.30 394.72
Accounts Payable
5.93 5.93 8.73 2.22
Accrued Expenses
15.57 20.00 16.17 25.31
Total current liabilities
21.56 25.95 25.00 27.84
Total non-current liabilities
— — 0.32 0.03
Total liabilities
21.56 25.95 25.32 27.88
Additional Paid In Capital
673.88 711.85 772.21 864.96
Common Stock (Net)
0.00 0.00 0.01 0.01
Retained Earnings
(369.10) (404.64) (447.96) (497.85)
Common Equity (Total)
305.00 307.22 323.98 366.84
Shareholders Equity (Total)
305.00 307.22 323.98 366.84
Shareholders Equity and Liabilities (Total)
326.56 333.17 349.30 394.72
Shares (Common)
40.85 42.45 45.31 48.32
Shareholders Equity (Tangible)
305.00 307.22 323.98 366.84
Net Debt
(300.27) (312.82) (326.38) (373.12)

Fold the line items

In millions of $ except per-share values · columns are period end dates